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sites, but it can be found anywhere. The authors present a case report of a 35-year-old male who was submitted to an eventless
left external dacryocystorhinostomy (DCR) due to epiphora. During the surgery no tumors or anomalous tissues were visualized.
Five months later the patient presented a painless mass at the lower medial quadrant of the left orbit, near the lacrimal fossa. A
computed tomography, a magnetic resonance imaging and an orbital ultrasound were performed. A round, very vascularized and
highly contrast enhanced mass was found. An anterior orbitotomy was done. Histological aspects and immunohistochemical mark-
ers were consistent with STF. The tumor was not visualized during the DCR. The authors think that the growth of the tumor and the
weakening of the tissues in the medial canthus after the DCR allowed the tumor to move anteriorly within the orbit. 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Saudi Ophthalmological Society, King Saud University.
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The solitary fibrous tumor (SFT) is a rare spindle cell tumor
that most often occurs in the pleura, mediastinum and other
serosal sites.1–5 The SFT, the hemangiopericytoma, the giant
cell angiofibroma, and the giant cell fibroblastoma are con-
sidered to be within the same disease spectrum, due to over-
lapping of morphologic and immunophenotypic findings.2 In
the orbit it is rare and almost always extraconic, but it can be
found anywhere.6 It is a slow growing tumor with a mostly
benign behavior. The gold standard treatment is surgery,
however Nafiseh Hashemi et al.7 treated a SFT with emboliza-
tion followed by surgery.Case report
A healthy 35-year-old man was observed in our depart-
ment due to epiphora of the left eye. The lacrimal probing
was done and confirmed nasolacrimal duct obstruction. The
patient was submitted to an eventless left external dacry-
ocystorhinostomy (DCR). During the surgery no tumors or
anomalous tissues were visualized.
Five months later, the patient presented a painless mass at
the lower medial quadrant of the left orbit, near the lacrimal
fossa, without inflammatory signs or epiphora. The visual acu-
ity was 20/20, indirect ophthalmoscopy and ocular motility
were normal. An orbital computed tomography revealed a
round lesion with intense and homogeneous contraste:
al.com
Fig. 1. Top- CT and STF; Botton: MRI and US.
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orbit (Fig. 1). The diagnosis of cavernous angioma or neo-
plasia were considered. The orbital magnetic resonance
imaging showed a round lesion with hyposignal on T1 and
low signal intensity on long TR, with intense and homoge-
neous contrast enhancement (Gd-DTPA). An inflammatory
lesion or a non-aggressive neoplasia were considered as dif-
ferential diagnosis. An orbital ultrasound revealed a solid
nodular lesion, homogeneous, hypoechoic and highly vascu-
larized without the usual features of a hemangioma or other
vascular malformation and compatible with a giant cell
angiofibroma.Fig. 2. Histology and imAn anterior orbitotomy with transconjunctival approach
was performed and a round, well encapsulated, elastic, red
lesion was removed.
The lesion weighted 4 g, and had the following dimensions:
2,5  1,6  1,4 cm. Histologically, it was a highly vascularized
lesion with cancer cells sometimes ovoid, sometimes fusiform,
inside a collagenous stroma with slight pleomorphism and
marked capillary vascularization in a pattern compatible with
a mesenchymal neoplasia. The immunohistochemistry (Fig. 2)
was CD 34+, Bcl2+, CD117, S100, SMA.
In the following three years there was no recurrence of the
lesion.munohistochemistry.
318 M. Araújo et al.Discussion and conclusion
Clinical examination, imaging, and histology are non-
specific in the evaluation of the SFT of the orbit.4,8 Therefore,
immunohistochemical markers are fundamental for the diag-
nosis.6 The CD34 is considered the most reliable marker for
orbital STF, but it is nonspecific.9,11 The expression of Bcl-2
is very high in STF and negative in most malignant mesothe-
liomas.9 Thus, the combination of these two immunohisto-
chemical markers increase the diagnostic accuracy. In our
patient, the histological pattern and the immunohistochem-
istry (CD34+, Bcl-2+) are consistent with a STF of the orbit.
In fact, the peripheral nerve sheath tumors are S100+,6 the
leiomyosarcoma and mesothelioma are CD34, so both are
excluded. The GISTs may be CD34 and SMA positive or neg-
ative, depending on the site of the tumor in the gastrointesti-
nal tract,10 but are CD117+ and Bcl-2+, so are also excluded.
An orbital STF is a slow growing, indolent and mostly
nonaggressive tumor.5 The proliferation of cells may result
from the high expression of Bcl2, a potent inhibitor of apop-
tosis,9, and not from cell mitosis which are scarse in SFT.
In this patient the tumor was not visualized during the
DCR. Therefore, we think that the growth of the tumor and
the weakening of the tissues in the medial canthus after the
DCR allowed the tumor to move anteriorly within the orbit.
The treatment of the orbital SFT consists in complete surgical
removal12 which was performed. No recurrences occurred
within the three year follow-up.
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